This post was originally published on this site
AbbVie announced earnings per share of $3.66 on revenue of $14.81. Analysts polled by Investing.com anticipated EPS of $3.58 on revenue of $14.93B.
AbbVie shares are up 13% from the beginning of the year, still down 12.74% from its 52 week high of $175.91 set on April 8.
AbbVie shares lost 0.03% in pre-market trade following the report.
AbbVie’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
